| Literature DB >> 24586432 |
Nicholas E Ilott1, Tomasz Schneider2, Jonathan Mill3, Leonard Schalkwyk4, Giovana Brolese5, Lisiane Bizarro5, Ian P Stolerman6, Emma Dempster3, Philip Asherson4.
Abstract
Gestational exposure to environmental toxins such as nicotine may result in detectable gene expression changes in later life. To investigate the direct toxic effects of prenatal nicotine exposure on later brain development, we have used transcriptomic analysis of striatal samples to identify gene expression differences between adolescent Lister Hooded rats exposed to nicotine in utero and controls. Using an additional group of animals matched for the reduced food intake experienced in the nicotine group, we were also able to assess the impact of imposed food-restriction on gene expression profiles. We found little evidence for a role of gestational nicotine exposure on altered gene expression in the striatum of adolescent offspring at a significance level of p<0.01 and |log2 fold change >0.5|, although we cannot exclude the possibility of nicotine-induced changes in other brain regions, or at other time points. We did, however, find marked gene expression differences in response to imposed food-restriction. Food-restriction resulted in significant group differences for a number of immediate early genes (IEGs) including Fos, Fosb, Fosl2, Arc, Junb, Nr4a1 and Nr4a3. These genes are associated with stress response pathways and therefore may reflect long-term effects of nutritional deprivation on the development of the stress system.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24586432 PMCID: PMC3929494 DOI: 10.1371/journal.pone.0088896
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Nicotine administration and food-restriction have effects on pregnancy and birth characteristics.
| Measure | Timing | F | P-value | Con | Nic | Con-Pf |
| Dams | ||||||
| Mean body weight | Week before pregnancy | 12.38 | 2.50E-04 | 252.2±6.2 | 213.9±6.5 | 223.4±4.1 |
| (g) | Pregnancy | 13.30 | 1.63E-04 | 289.1±6.7 | 247.8±6.8 | 260.3±3.5 |
| Mean food consumption | Week before pregnancy | 13.06 | 1.83E-04 | 15.6±0.4 | 13.3±0.4 | 13.7±0.0 |
| (g/day) | Pregnancy | 10.23 | 7.24E-04 | 21.4±0.4 | 17.8±0.9 | 19.3±0.0 |
| Mean food consumption | Week before pregnancy | 0.05 | 0.95 | 61.9±1.3 | 62.3±1.5 | 61.7±1.2 |
| (g/Kg bodyweight/day) | Pregnancy | 0.82 | 0.46 | 74.3±1.4 | 71.7±2.3 | 74.2±1.1 |
| Mean sol | Week before pregnancy | 19.14 | 1.53E-05 | 24.9±1.2 | 14.5±0.7 | 18.9±1.4 |
| (ml) | Pregnancy | 33.40 | 2.16E-07 | 45.0±2.7 | 21.8±1.7 | 38.0±1.6 |
| Mean sol | Week before pregnancy | 10.97 | 4.97E-04 | 98.5±3.6 | 68.2±3.4 | 84.5±5.7 |
| (ml/Kg bodyweight/day) | Pregnancy | 33.56 | 2.07E-07 | 155.1±6.7 | 88.1±6.2 | 146.0±5.8 |
| Offspring | ||||||
| Bodyweight (g) | PND1 | 5.8 | 9.08E-03 | 5.3±0.1 | 4.7±0.1 | 5.1±0.1 |
*p<0.05 compared to Con, #p<0.05 compared to Con-Pf.
Figure 1Volcano plots representing group comparisons for all genes included in the analysis.
x-axes represent log2 fold-changes and y-axes represent the –log10(p-values) associated with the t-statistic. Vertical dotted lines are positioned at a log2 fold-change of 0.5 or −0.5 and horizontal dotted lines are positioned at the equivalent of p = 0.01. In red are those genes that are differentially expressed at p<0.01 and log2 fold-change>0.5 or <−0.5. A) Nic vs. Con B) Nic vs. Con-Pf and C) Con vs. Con-Pf.
Results from Student's t-tests for all three group comparisons.
| Comparison | Probe-set ID | t-statistic | p-value | FDR q-value | Log2 (FC) | Accession Number | Gene | Description |
| Nic vs. Con | 10868302 | 3.97 | 2.20E-03 | 0.24 | −0.50 | AY539927 | LRRGT00176 mRNA | - |
| Nic vs. Con-Pf | 10727717 | 4.33 | 1.79E-03 | 0.26 | 1.44 | NM_153626 | Npas4 | neuronal PAS domain protein 4 |
| 10886031 | 5.80 | 3.81E-05 | 0.04 | 0.98 | NM_022197 | Fos | FBJ osteosarcoma oncogene | |
| 10899387 | 5.02 | 5.26E-04 | 0.17 | 0.97 | NM_024388 | Nr4a1 | nuclear receptor subfamily 4, group A, member 1 | |
| 10832802 | 6.39 | 1.29E-05 | 0.03 | 0.92 | NM_053633 | Egr2 | early growth response 2 | |
| 10904511 | 6.61 | 3.33E-05 | 0.04 | 0.85 | NM_019361 | Arc | activity-regulated cytoskeleton-associated protein | |
| 10868940 | 3.97 | 1.32E-03 | 0.23 | 0.76 | NM_031628 | Nr4a3 | nuclear receptor subfamily 4, group A, member 3 | |
| 10806585 | 5.68 | 4.57E-05 | 0.05 | 0.65 | NM_021836 | Junb | jun B proto-oncogene | |
| 10732652 | 4.62 | 3.58E-04 | 0.15 | 0.64 | NM_053769 | Dusp1 | dual specificity phosphatase 1 | |
| 10844339 | 5.48 | 1.05E-04 | 0.09 | 0.63 | NM_145677 | Slc25a25 | solute carrier family 25 | |
| 10940628 | 4.16 | 1.00E-03 | 0.22 | 0.57 | NM_001013146.1 | Fosb | Rattus norvegicus FBJ osteosarcoma oncogene B (Fosb) | |
| 10940647 | 4.18 | 1.01E-03 | 0.22 | 0.56 | NM_012954.1 | Fosl2 | Rattus norvegicus fos-like antigen 2 (Fosl2) | |
| 10834031 | 7.77 | 1.25E-06 | 7.80E-03 | 0.51 | NM_001079893 | Dusp14 | dual specificity phosphatase 14 | |
| Con vs. Con-Pf | 10899387 | −12.32 | 2.94E-09 | 1.49E-05 | 1.44 | NM_024388 | Nr4a1 | nuclear receptor subfamily 4, group A, member 1/ |
| 10832802 | −9.06 | 3.07E-07 | 2.27E-04 | 1.22 | NM_053633 | Egr2 | early growth response 2 | |
| 10727717 | −3.43 | 6.01E-03 | 1.29E-01 | 1.16 | NM_153626 | Npas4 | neuronal PAS domain protein 4 | |
| 10868940 | −5.73 | 3.94E-05 | 8.09E-03 | 1.11 | NM_031628 | Nr4a3 | nuclear receptor subfamily 4, group A, member 3 | |
| 10904511 | −9.25 | 2.55E-07 | 2.10E-04 | 1.10 | NM_019361 | Arc | activity-regulated cytoskeleton-associated protein | |
| 10886031 | −6.68 | 9.74E-06 | 2.88E-03 | 1.07 | NM_022197 | Fos | FBJ osteosarcoma oncogene | |
| 10806585 | −7.30 | 1.84E-06 | 8.50E-04 | 0.79 | NM_021836 | Junb | jun B proto-oncogene | |
| 10940628 | −5.45 | 6.88E-05 | 1.30E-02 | 0.78 | NM_001013146.1 | Fosb | Rattus norvegicus FBJ osteosarcoma oncogene B (Fosb) | |
| 10760080 | −11.43 | 4.83E-09 | 1.49E-05 | 0.76 | NM_001002829 | Rasl11a | RAS-like family 11 member A | |
| 10940647 | −5.35 | 8.89E-05 | 1.49E-02 | 0.74 | NM_012954.1 | Fosl2 | Rattus norvegicus fos-like antigen 2 (Fosl2) | |
| 10872626 | −10.37 | 1.86E-08 | 3.44E-05 | 0.70 | NM_153727 | Gpr3 | G protein-coupled receptor 3 | |
| 10732652 | −5.42 | 5.86E-05 | 1.14E-02 | 0.70 | NM_053769 | Dusp1 | dual specificity phosphatase 1 | |
| 10844339 | −5.94 | 2.79E-05 | 6.08E-03 | 0.67 | NM_145677 | Slc25a25 | solute carrier family 25 | |
| 10834031 | −8.78 | 2.37E-07 | 2.10E-04 | 0.66 | NM_001079893 | Dusp14 | dual specificity phosphatase 14 | |
| 10716080 | −11.05 | 4.04E-08 | 5.97E-05 | 0.62 | NM_133578 | Dusp5 | dual specificity phosphatase 5 | |
| 10768332 | −11.81 | 6.03E-09 | 1.49E-05 | 0.61 | NM_053453 | Rgs2 | regulator of G-protein signaling 2 | |
| 10863676 | −6.15 | 2.26E-05 | 5.39E-03 | 0.61 | NM_019137 | Erg4 | early growth response 4 | |
| 10815763 | −5.36 | 7.19E-05 | 1.33E-02 | 0.57 | NM_001107679 | Tiparp | TCDD-inducible poly(ADP-ribose) polymerase | |
| 10896793 | −6.80 | 9.41E-06 | 2.88E-03 | 0.57 | NM_023985 | Trib3 | tribbles homolog 1 (Drosophila) | |
| 10719432 | −5.45 | 1.10E-04 | 1.60E-02 | 0.56 | ENSRNOT00000022556 | Fosb | FBJ osteosarcoma oncogene B | |
| 10701846 | −14.66 | 6.90E-06 | 2.32E-03 | 0.56 | NM_053698 | Cited2 | p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | |
| 10800919 | −8.48 | 8.32E-07 | 4.73E-04 | 0.55 | NM_012551 | Egr1 | early growth response 1 | |
| 10792035 | −7.39 | 5.87E-06 | 2.28E-03 | 0.55 | NM_022199 | Dusp4 | dual specificity phosphatase 4 | |
| 10780205 | −4.99 | 2.18E-04 | 2.44E-02 | 0.51 | NM_031056 | Mmp14 | matrix metallopeptidase 14 (membrane-inserted) | |
| 10710028 | −8.00 | 7.58E-07 | 4.67E-04 | 0.51 | NM_024362 | Arntl | aryl hydrocarbon receptor nuclear translocator-like | |
| 10833811 | 4.32 | 9.86E-04 | 5.84E-02 | -0.56 | - | - | - |
Shown are all genes reaching significance at p<0.01 and |FC≥0.5| ordered by FC. In bold are those genes that are up-regulated in both the Nic vs. Con and Con-Pf vs. Con comparisons.
qRT-PCR results for differentially expressed genes in microarray analysis.
| Con vs Con-Pf | Nic vs con-Pf | |||
| T | p.value | t | p.value | |
| Fosl2 | −4.46 | 1.91E-04 | 3.17 | 3.10E-03 |
| Fos | −6.10 | 5.13E-06 | 4.42 | 3.42E-04 |
| Nr4a1 | −2.96 | 4.28E-03 | 3.66 | 1.11E-03 |
| Nr4a3 | −4.46 | 1.91E-04 | 3.17 | 3.10E-03 |
| Slc25a5 | −1.72 | 0.05 | 1.98 | 0.04 |
| Arc | −3.78 | 8.54E-04 | 3.72 | 1.11E-03 |
| Junb | −1.78 | 0.05 | 1.59 | 0.07 |
| Dusp1 | −3.71 | 8.40E-04 | 3.17 | 2.94E-03 |
| Egr2 | −2.39 | 0.01 | 1.76 | 0.05 |
Figure 2qRT-PCR validation of 9 food-restriction-sensitive genes.
The y-axis represents the log2(fold changes) observed in both comparisons involving the food restricted group. Differences in gene expression using qRT-PCR were consistent with microarray data. The dashed line represents the fold change cut-off (log2(fold change) >0.5) used in the microarray analysis.
IPA identified a functional network of genes that included 7 genes differentially expressed due to food-restriction.
| Network functions | Molecules in network | Score |
| Cell Cycle, Gene Expression, Cellular Development | 26s Proteasome, Akt, ATP9A, C8ORF4, Creb, CREB-NFkB, CyclinA, DUSP1, DUSP14, EGR2, ERK1/2, FOS, FSH, GK7P, hCG, IG9, Insulin, Jnk, JUNB, LDL, Lh, LOC81691, Mapk, Mek, NFkB (complex), NGF, NR4A1, NR4A3, OVGP1, PDGF BB, PDLIM3, Pka,Pkc(s), TP53I11, ZFP386 | 19 |
In bold are the genes that were represented from our list of differentially expressed genes.
Figure 3Ingenuity Pathways Analysis of genes identified as differentially expressed in the Nic vs. Con-Pf and the Con vs. Con-Pf comparisons.
On the left is the top network identified consisting of 7/12 genes in our list, and on the right is the top associated canonical pathway. Highlighted red are the genes in our list that were over-expressed due to food-restriction.
The top 5 canonical pathways identified for genes differentially expressed due to food-restriction.
| Canonical pathway | p-value | Ratio |
| Corticotrophin Releasing Hormone Signalling | 1.98E-03 | 2/136 (0.015) |
| NRF2-mediated Oxidative Stress Response | 3.91E-03 | 2/183 (0.011) |
| RAR Activation | 3.91E-03 | 2/181 (0.011) |
| ERK/MAPK Signalling | 4.33E-03 | 2/192 (0.01) |
| Glucocorticoid Receptor Signalling | 8.64E-03 | 2/280 (0.007) |
Figure 4Gene set enrichment analysis (GSEA) of the GO pathway “RESPONSE_TO_STRESS” in the Con vs. Con-Pf comparison.
The input gene list was all genes in the microarray analysis ranked by –log10(p-value)×log2(fold change). The enrichment score profile displays an enrichment of pathway hits at the top of the list, suggesting multiple top-ranked genes involved in the “Response to stress” pathway.
Genes in the core enrichment (i.e. contributing to the maximum enrichment score for the gene set “RESPONSE_TO_STRESS”) from each gene list.
| Nic vs. Con-Pf | Con vs. Con-Pf | ||||||||
| Gene | Rank in gene list | Gene | Rank in gene list | Gene | Rank in gene list | Gene | Rank in gene list | Gene | Rank in gene list |
| FOS | 1 | FOS | 5 | CIB1 | 404 | RELA | 896 | TNFRSF1A | 1440 |
| DUSP1 | 8 | DUSP1 | 15 | ATF4 | 437 | SMAD7 | 899 | MT3 | 1478 |
| GADD45G | 32 | BTG2 | 32 | TP53I11 | 452 | TGFB1 | 925 | CDO1 | 1532 |
| BTG2 | 38 | BCL6 | 45 | DNAJB1 | 463 | EEF1E1 | 1003 | AKR1B1 | 1624 |
| PPP1R15A | 50 | GADD45A | 63 | RAD23A | 498 | PRDX6 | 1055 | STIP1 | 1638 |
| HSPB1 | 72 | HSPB1 | 78 | DNAJB4 | 499 | ATOX1 | 1059 | UBE2B | 1641 |
| PLOD1 | 78 | SCG2 | 80 | DDIT3 | 615 | MSRA | 1068 | MAP4K2 | 1662 |
| BCL6 | 99 | PPP1R15A | 85 | CHRNB2 | 683 | AQP9 | 1114 | XRCC4 | 1666 |
| PLAT | 178 | GADD45G | 93 | TRIAP1 | 708 | GPX3 | 1166 | EIF2B2 | 1678 |
| SMAD7 | 204 | DNAJB5 | 134 | NDUFS8 | 709 | XRCC6BP1 | 1275 | TP73 | 1697 |
| SCG2 | 214 | ALKBH1 | 216 | CHRNA4 | 734 | SUMO1 | 1294 | ||
| GADD45A | 227 | ALOX5AP | 240 | RTN4RL1 | 806 | NDUFA6 | 1300 | ||
| DNAJB5 | 302 | PLAT | 243 | PCBP4 | 871 | GAP43 | 1331 | ||
| DDIT3 | 315 | PDLIM1 | 255 | RNF7 | 895 | RPA1 | 1405 | ||